End-of-day quote
HANOI S.E.
23:00:00 02/05/2024 BST
|
5-day change
|
1st Jan Change
|
3,200
VND
|
0.00%
|
|
0.00%
|
-17.95%
|
Fiscal Period: December |
2018
|
2019
|
---|
Capitalization
1 |
1,030,398
|
930,070
|
Enterprise Value (EV)
1 |
953,166
|
967,467
|
P/E ratio
|
4.79
x
|
4.23
x
|
Yield
|
-
|
11.4%
|
Capitalization / Revenue
|
2.29
x
|
1.91
x
|
EV / Revenue
|
2.11
x
|
1.99
x
|
EV / EBITDA
|
4.23
x
|
4.15
x
|
EV / FCF
|
-
|
6,037,215
x
|
FCF Yield
|
-
|
0%
|
Price to Book
|
2.12
x
|
1.26
x
|
Nbr of stocks (in thousands)
|
53,147
|
53,147
|
Reference price
2 |
19,388
|
17,500
|
Announcement Date
|
09/04/20
|
09/04/20
|
Fiscal Period: December |
2018
|
2019
|
---|
Net sales
1 |
450,796
|
487,382
|
EBITDA
1 |
225,304
|
233,313
|
EBIT
1 |
222,645
|
226,982
|
Operating Margin
|
49.39%
|
46.57%
|
Earnings before Tax (EBT)
1 |
219,663
|
224,676
|
Net income
1 |
215,098
|
219,842
|
Net margin
|
47.72%
|
45.11%
|
EPS
2 |
4,047
|
4,137
|
Free Cash Flow
|
-
|
160,251
|
FCF margin
|
-
|
32.88%
|
FCF Conversion (EBITDA)
|
-
|
68.68%
|
FCF Conversion (Net income)
|
-
|
72.89%
|
Dividend per Share
|
-
|
2,000
|
Announcement Date
|
09/04/20
|
09/04/20
|
Fiscal Period: December |
2018
|
2019
|
---|
Net Debt
1 |
-
|
37,397
|
Net Cash position
1 |
77,232
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.1603
x
|
Free Cash Flow
|
-
|
160,251
|
ROE (net income / shareholders' equity)
|
-
|
32.9%
|
ROA (Net income/ Total Assets)
|
-
|
18.6%
|
Assets
1 |
-
|
1,180,590
|
Book Value Per Share
2 |
9,157
|
13,835
|
Cash Flow per Share
2 |
1,611
|
201.0
|
Capex
1 |
50,244
|
67,656
|
Capex / Sales
|
11.15%
|
13.88%
|
Announcement Date
|
09/04/20
|
09/04/20
|
|
1st Jan change
|
Capi.
|
---|
| -17.95% | 16.52M | | +26.83% | 681B | | +21.85% | 556B | | -4.91% | 361B | | +17.15% | 325B | | +5.65% | 285B | | +13.68% | 235B | | +3.65% | 199B | | -11.12% | 189B | | -3.84% | 157B |
Other Pharmaceuticals
|